載入...
Overview of the Side-Effects of FDA- and/or EMA-Approved Targeted Therapies for the Treatment of Hematological Malignancies
In the last decade there has been tremendous effort in offering better therapeutic management strategies to patients with hematologic malignancies. These efforts have ranged from biological to clinical approaches and resulted in the rapid development of new approaches. The main “problem” that comes...
Na minha lista:
| 發表在: | J Clin Med |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7565707/ https://ncbi.nlm.nih.gov/pubmed/32911829 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9092903 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|